Compounds > aminoimidazole carboxamide
Page last updated: 2024-08-21

aminoimidazole carboxamide and transforming growth factor beta

aminoimidazole carboxamide has been researched along with transforming growth factor beta in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choudhury, GG; Feliers, D; Foretz, M; Kasinath, BS; Lee, MJ; Mahimainathan, L; Mariappan, MM; Musi, N; Sataranatarajan, K; Viollet, B; Weinberg, JM1
Chang, JW; Kim, JH; Kim, JS; Kim, SB; Lee, JH; Lee, SK; Park, JS1
Miyamoto, S; Sharma, K; You, YH; Zhao, J1
Alenazi, FSH; Briski, KP; Ibrahim, BA1
Choi, YK; Jang, SY; Jeon, JH; Jeong, WI; Jung, GS; Kang, YN; Kim, MK; Lee, IK; Park, KG; Park, SY; Shin, EC1
Dong, Z; George, J; Hu, L; Lv, Y; Su, L; Wang, J; Wu, Y1
Cheng, WC; Chiu, FY; Fang, SH; Hsieh, KL; Huang, KH; Huang, MY; Huang, SP; Li, CY; Lin, IL; Liu, PL; Su, CC; Yeh, HC1
Calhoun, WJ; Kakumanu, RD; Kaphalia, BS; Kaphalia, L; Srinivasan, MP1

Other Studies

8 other study(ies) available for aminoimidazole carboxamide and transforming growth factor beta

ArticleYear
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:2

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Metformin; Multienzyme Complexes; Phosphoproteins; Protein Serine-Threonine Kinases; Rats; Ribonucleosides; Transforming Growth Factor beta

2007
AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition.
    American journal of physiology. Renal physiology, 2013, Mar-15, Volume: 304, Issue:6

    Topics: Albumins; Aldosterone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Cell Line; Epithelial-Mesenchymal Transition; Glucose; Heme Oxygenase-1; Humans; Metformin; NADPH Oxidase 4; NADPH Oxidases; Nephrosclerosis; Pyrazoles; Pyrimidines; Reactive Oxygen Species; Ribonucleosides; Thioredoxins; Transforming Growth Factor beta

2013
AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.
    American journal of physiology. Renal physiology, 2015, May-15, Volume: 308, Issue:10

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Cell Nucleus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glucose; Hypoglycemic Agents; In Vitro Techniques; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; Ribonucleotides; Signal Transduction; Smad4 Protein; Streptozocin; Transforming Growth Factor beta

2015
Estradiol Regulates Dorsal Vagal Complex Signal Transduction Pathway Transcriptional Reactivity to the AMPK Activator 5-Aminoimidazole-4-Carboxamide-Riboside (AICAR).
    Journal of molecular neuroscience : MN, 2015, Volume: 56, Issue:4

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Brain Stem; Estradiol; Female; Janus Kinases; Neurons; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, Notch; Ribonucleotides; Second Messenger Systems; Serpins; STAT Transcription Factors; Transforming Growth Factor beta; Tumor Suppressor Protein p53; Wnt Proteins

2015
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:10

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line, Tumor; Gluconeogenesis; Hepacivirus; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Metformin; Receptors, Cytoplasmic and Nuclear; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta

2015
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
    Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:3

    Topics: Actins; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bile Ducts; Disease Models, Animal; Endothelial Cells; Hepatic Stellate Cells; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta

2019
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
    International journal of molecular sciences, 2019, Apr-03, Volume: 20, Issue:7

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Drug Synergism; Epithelial-Mesenchymal Transition; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases; Transforming Growth Factor beta

2019
Ethanol Exposure Impairs AMPK Signaling and Phagocytosis in Human Alveolar Macrophages: Role of Ethanol Metabolism.
    Alcoholism, clinical and experimental research, 2019, Volume: 43, Issue:8

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Chemokine CCL2; Endoplasmic Reticulum Stress; Esters; Ethanol; Fatty Acids; Humans; Interleukins; Macrophages, Alveolar; Oxidative Stress; Phagocytosis; Protein Kinase Inhibitors; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta

2019